29 related articles for article (PubMed ID: 19952318)
1. Vibrio cholerae in traveler from Haiti to Canada.
Gilmour MW; Martel-Laferriere V; Lévesque S; Gaudreau C; Bekal S; Nadon C; Bourgault AM
Emerg Infect Dis; 2011 Jun; 17(6):1124-5. PubMed ID: 21749787
[No Abstract] [Full Text] [Related]
2. Characterisation of
Mwape K; Kwenda G; Kalonda A; Mwaba J; Lukwesa-Musyani C; Ngulube J; Smith AM; Mwansa J
Pan Afr Med J; 2020; 35():32. PubMed ID: 32499849
[TBL] [Abstract][Full Text] [Related]
3.
Rashed SM; Hasan NA; Alam M; Sadique A; Sultana M; Hoq MM; Sack RB; Colwell RR; Huq A
Front Microbiol; 2017; 8():252. PubMed ID: 28270803
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1.
Khan WA; Saha D; Ahmed S; Salam MA; Bennish ML
PLoS One; 2015; 10(8):e0134921. PubMed ID: 26271050
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial Drug Resistance of Vibrio cholerae, Democratic Republic of the Congo.
Miwanda B; Moore S; Muyembe JJ; Nguefack-Tsague G; Kabangwa IK; Ndjakani DY; Mutreja A; Thomson N; Thefenne H; Garnotel E; Tshapenda G; Kakongo DK; Kalambayi G; Piarroux R
Emerg Infect Dis; 2015 May; 21(5):847-51. PubMed ID: 25897570
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and genetic characterization of Vibrio cholerae O1 isolated from various regions of Kenya between 2007 and 2010.
Mercy N; Mohamed AA; Zipporah N; Chowdhury G; Pazhani GP; Ramamurthy T; Boga HI; Kariuki SM; Joseph O
Pan Afr Med J; 2014; 19():8. PubMed ID: 25584121
[TBL] [Abstract][Full Text] [Related]
7. Genetic traits of Vibrio cholerae O1 Haitian isolates that are absent in contemporary strains from Kolkata, India.
Ghosh P; Naha A; Pazhani GP; Ramamurthy T; Mukhopadhyay AK
PLoS One; 2014; 9(11):e112973. PubMed ID: 25415339
[TBL] [Abstract][Full Text] [Related]
8. Overcoming barriers in evaluating outbreaks of diarrheal disease in resource poor settings: assessment of recurrent outbreaks in Chobe District, Botswana.
Alexander KA; Blackburn JK
BMC Public Health; 2013 Aug; 13():775. PubMed ID: 23971427
[TBL] [Abstract][Full Text] [Related]
9. Cholera.
Harris JB; LaRocque RC; Qadri F; Ryan ET; Calderwood SB
Lancet; 2012 Jun; 379(9835):2466-2476. PubMed ID: 22748592
[TBL] [Abstract][Full Text] [Related]
10. Genomic diversity of 2010 Haitian cholera outbreak strains.
Hasan NA; Choi SY; Eppinger M; Clark PW; Chen A; Alam M; Haley BJ; Taviani E; Hine E; Su Q; Tallon LJ; Prosper JB; Furth K; Hoq MM; Li H; Fraser-Liggett CM; Cravioto A; Huq A; Ravel J; Cebula TA; Colwell RR
Proc Natl Acad Sci U S A; 2012 Jul; 109(29):E2010-7. PubMed ID: 22711841
[TBL] [Abstract][Full Text] [Related]
11. Multi-drug resistant Vibrio cholerae O1 variant El Tor isolated in northern Vietnam between 2007 and 2010.
Tran HD; Alam M; Trung NV; Van Kinh N; Nguyen HH; Pham VC; Ansaruzzaman M; Rashed SM; Bhuiyan NA; Dao TT; Endtz HP; Wertheim HFL
J Med Microbiol; 2012 Mar; 61(Pt 3):431-437. PubMed ID: 22016560
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic, genotypic, and antibiotic sensitivity patterns of strains isolated from the cholera epidemic in Zimbabwe.
Islam MS; Mahmud ZH; Ansaruzzaman M; Faruque SM; Talukder KA; Qadri F; Alam M; Islam S; Bardhan PK; Mazumder RN; Khan AI; Ahmed S; Iqbal A; Chitsatso O; Mudzori J; Patel S; Midzi SM; Charimari L; Endtz HP; Cravioto A
J Clin Microbiol; 2011 Jun; 49(6):2325-7. PubMed ID: 21471347
[TBL] [Abstract][Full Text] [Related]
13. Vibrio cholerae O1 variant with reduced susceptibility to ciprofloxacin, Western Africa.
Quilici ML; Massenet D; Gake B; Bwalki B; Olson DM
Emerg Infect Dis; 2010 Nov; 16(11):1804-5. PubMed ID: 21029554
[No Abstract] [Full Text] [Related]
14. Susceptibility to fluoroquinolones of Vibrio cholerae O1 isolated from diarrheal patients in Zimbabwe.
Islam MS; Midzi SM; Charimari L; Cravioto A; Endtz HP
JAMA; 2009 Dec; 302(21):2321-2. PubMed ID: 19952318
[No Abstract] [Full Text] [Related]
15. Diarrhoeal outbreak of Vibrio cholerae 01 Inaba in Delhi.
Rajeshwari K; Gupta A; Dubey AP; Uppal B; Singh MM
Trop Doct; 2008 Apr; 38(2):105-7. PubMed ID: 18453505
[TBL] [Abstract][Full Text] [Related]
16. Changing characteristics of Vibrio cholerae: emergence of multidrug resistance and non-O1, non-O139 serogroups.
Chandrasekhar MR; Krishna BV; Patil AB
Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):1092-7. PubMed ID: 19062701
[TBL] [Abstract][Full Text] [Related]
17. Emergence of Vibrio cholerae O1 biotype El Tor serotype Inaba causing outbreaks of cholera in Orissa, India.
Pal BB; Khuntia HK; Samal SK; Das SS; Chhotray GP
Jpn J Infect Dis; 2006 Aug; 59(4):266-9. PubMed ID: 16936349
[TBL] [Abstract][Full Text] [Related]
18. Virulence and multidrug resistance patterns of Vibrio cholerae O1 isolates from diarrheal outbreaks of South India during 2006-2009.
Balaji K; Okonjo PA; Thenmozhi R; Karutha Pandian S
Microb Drug Resist; 2013 Jun; 19(3):198-203. PubMed ID: 23289410
[TBL] [Abstract][Full Text] [Related]
19. What do I need to know about fluoroquinolones for children?
Meesters K; Raes AM; Vande Walle JG
Arch Dis Child Educ Pract Ed; 2019 Oct; 104(5):254-258. PubMed ID: 29987158
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
